1. importsource = "00280836-2010-04-15.txt"
Se encontraron 141 resultados.
Artículo:

Functional genomic screen for modulators of ciliogenesis and cilium length

Autor:

Joon Kim

Resumen:

Primary cilia are tiny hair-like structures expressed on the surface of eukaryotic cells. They participate in a range of processes, such as sensing the extracellular environment and regulating signalling pathways during development. Here, a functional genomic screen is presented that used RNA interference to identify human genes involved in controlling ciliogenesis. Several positive and negative ciliogenesis modulators with broad-ranging functions were found

Página:

1048

Publicación:

Nature

Volúmen:

464

Número:

7291

Periodo:

15 Abril 2010

ISSN:

00280836

SrcID:

00280836-2010-04-15.txt

  • Documento número 1206237
  • Actualizado el martes, 10 de julio de 2018 11:33:56 a. m.
  • Creado el martes, 10 de julio de 2018 11:33:56 a. m.
  • Enlace directo
Artículo:

Therapeutic antibody targeting of individual Notch receptors

Autor:

Yan Wu

Resumen:

The four receptors of the Notch family are transmembrane proteins through which mammalian cells communicate to regulate cell fate and growth. Aberrant signalling through each receptor has been linked to disease, so the Notch pathway is a compelling drug target. But current drugs cannot distinguish between the different Notch proteins. Here, phage display technology has been used to generate highly specialized antibodies, enabling the functions of Notch1 and Notch2 to be discriminated in humans and mice

Página:

1052

Publicación:

Nature

Volúmen:

464

Número:

7291

Periodo:

15 Abril 2010

ISSN:

00280836

SrcID:

00280836-2010-04-15.txt

  • Documento número 1206238
  • Actualizado el martes, 10 de julio de 2018 11:33:56 a. m.
  • Creado el martes, 10 de julio de 2018 11:33:56 a. m.
  • Enlace directo
Artículo:

Chemoprevention of colorectal cancer by targeting APC-deficient cells for apoptosis

Autor:

Ling Zhang

Resumen:

Cancer 'chemoprevention' uses substances to reverse, suppress or prevent the initial phase of carcinogenesis or the progression of neoplastic cells to cancer cells. Here it is shown that treatment with TRAIL proteins and all-trans-retinyl acetate can cause the death, in vitro and in vivo, of premalignant cells deficient in the adenomatous polyposis coli gene. Normal cells are unaffected. Selectively eliminating premalignant tumour cells in this way is thus an effective method for chemoprevention

Página:

1058

Publicación:

Nature

Volúmen:

464

Número:

7291

Periodo:

15 Abril 2010

ISSN:

00280836

SrcID:

00280836-2010-04-15.txt

  • Documento número 1206239
  • Actualizado el martes, 10 de julio de 2018 11:33:56 a. m.
  • Creado el martes, 10 de julio de 2018 11:33:56 a. m.
  • Enlace directo
Artículo:

Migrastatin analogues target fascin to block tumour metastasis

Autor:

Lin Chen

Resumen:

Analogues of migrastatin — a natural product secreted by Streptomyces — are potent inhibitors of tumour cell migration and metastasis. Here, the underlying mechanism is elucidated: these migrastatin analogues target and inhibit the activity of the actin-bundling protein fascin. Hence proteins such as fascin might present new molecular targets for cancer treatments

Página:

1062

Publicación:

Nature

Volúmen:

464

Número:

7291

Periodo:

15 Abril 2010

ISSN:

00280836

SrcID:

00280836-2010-04-15.txt

  • Documento número 1206240
  • Actualizado el martes, 10 de julio de 2018 11:33:56 a. m.
  • Creado el martes, 10 de julio de 2018 11:33:56 a. m.
  • Enlace directo
Artículo:

Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles

Autor:

Mark E. Davis

Resumen:

It has previously been shown in mice and non-human primates that systemically delivered short RNA molecules can inhibit gene expression. Here it is shown that a short interfering RNA (siRNA) can be systemically delivered, using nanoparticles, to a solid tumour in humans. The siRNA mediates cleavage of its target mRNA, thereby also reducing levels of the encoded protein. This proof-of-principle study confirms the potential of this technology for treating human disease

Página:

1067

Publicación:

Nature

Volúmen:

464

Número:

7291

Periodo:

15 Abril 2010

ISSN:

00280836

SrcID:

00280836-2010-04-15.txt

  • Documento número 1206241
  • Actualizado el martes, 10 de julio de 2018 11:33:56 a. m.
  • Creado el martes, 10 de julio de 2018 11:33:56 a. m.
  • Enlace directo